Frost & Sullivan Applauds Guerbet's Novel, Syringe-free CT Contrast Injector, FlowSens®
On Thursday, October 22, Frost & Sullivan honoured recipients of "2015 Excellence in Best Practices Awards". FlowSens®, Guerbet innovative injection solution, received the "2015 European Contrast Auto-injector-CT Imaging Modality New Product Innovation Award"
Based on its recent analysis of the market for contrast auto-injector computed tomography (CT) imaging modality, Frost & Sullivan recognizes Guerbet with the 2015 European Frost & Sullivan Award for New Product Innovation.
"Guerbet's pioneering syringe-free injector technology endows it with certain strategic advantages over its competitors," said Frost & Sullivan Senior Research Analyst Srikanth Kompalli. "Firstly, it broke new grounds in contrast media injectors by merging hydraulic technology with a syringe-free injection method to give the caregiver complete control over the delivery of the contrast agent with intuitive usage and safeguarding of procedures at every stage of the injection."
Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies.